Scoop: No­var­tis ax­es mid-stage de­pres­sion tri­al of ke­t­a­mine-like in­jec­tion

No­var­tis has scrapped a Phase II clin­i­cal tri­al of an in­ves­ti­ga­tion­al treat­ment for ma­jor de­pres­sive dis­or­der re­lat­ed to sui­ci­dal ideation, the Swiss Big Phar­ma con­firmed …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER